[To learn English]
Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline.
Firefly’s Firelink platform uses antibodies to deliver a protein-degrading drug directly into cancer cells, an approach J&J says could help attack tumors while sparing more healthy tissue than existing treatments.
强生公司周一宣布，将以 10 亿美元现金收购生物科技公司 Firefly Bio，以扩大其抗癌药物管线。
Firefly 的 Firelink 平台利用抗体将蛋白降解药物直接递送到癌细胞内。强生表示，这种方法能在攻击肿瘤的同时，比现有疗法更好地保护健康组织。
LearnEnglish Leave a remark